←
MedTech Dive3,640 posts
MedTech Dive avatar

MedTech Dive

@MedTechDive

We provide business journalism and in-depth insight into the most impactful news and trends shaping medical technology, Sign up here: dive.pub/mtd8

◷ Joined June 2018▧ 25 Photos and videos
MedTech Dive avatar
MedTech Dive@MedTechDive·4 Feb 2022

As companies manage through the omicron surge, and with the threat of potential future variants, the medical device industry is facing another year of uncertainty. MedTech Dive's three-part series explores key trends for the space in 2022. medtechdive.com/news/medtech…

MedTech Dive avatar
MedTech Dive@MedTechDive·19 Jul 2023

J&J subsidiary Abiomed's heart pumps can potentially interact with transcatheter aortic valve replacement (TAVR) stents, causing damage to the heart pump’s motor, according to a recall notice. buff.ly/46WEgM7

Post attachment
MedTech Dive avatar
MedTech Dive@MedTechDive·19 Jul 2023

A clinical trial found that overall, treating hearing loss in older adults had no effect on the rate of cognitive decline over three years. But a smaller analysis showed a big difference in adults who were at increased risk for cognitive decline. buff.ly/3Onr7oh

Post attachment
MedTech Dive avatar
MedTech Dive@MedTechDive·18 Jul 2023

Medtronic is recalling nearly 350,000 implantable defibrillators because the devices may deliver a reduced-energy shock, or no shock at all, when therapy is needed, the FDA said Tuesday. buff.ly/3ryAkRw

Post attachment
MedTech Dive avatar
MedTech Dive@MedTechDive·17 Jul 2023

Responding to concerns about the safety of hernia mesh devices, the FDA analyzed the adverse event reports it has received over the past 22 years and reviewed 45 research papers published in the past 11 years. buff.ly/44L5iEk

Post attachment
MedTech Dive avatar
MedTech Dive@MedTechDive·17 Jul 2023

QuidelOrtho’s recall of a test to detect heart attacks was labeled Class I by the FDA. The company received reports that the tests showed lower than expected troponin levels, and advised clinicians to immediately stop using them. buff.ly/44sUz1H

Post attachment
MedTech Dive avatar
MedTech Dive@MedTechDive·14 Jul 2023

The FDA approved Urotronic’s minimally invasive surgical treatment of symptoms linked to benign prostatic hyperplasia (BPH), offering another option to devices made by Teleflex and Boston Scientific. buff.ly/3NY7Ica

Post attachment
MedTech Dive avatar
MedTech Dive@MedTechDive·12 Jul 2023

The FDA has found paclitaxel-coated devices are unlikely to increase the risk of death when used to treat peripheral arterial disease, leading it to work with device-makers to update labeling. buff.ly/3NQvqGT

Post attachment